BF Biosciences inks deal with Lucky Core

MG News | September 04, 2024 at 10:30 AM GMT+05:00

0:00

September 04, 2024 (MLN): BF Biosciences Limited (BFBL)has entered into a contract manufacturing and supply agreement with Lucky Core Industries Limited (LCI) for the products "Esopase IV 40 mg" & "Etipro IV 40 mg", the company's filing on PSX revealed.

BFBL is a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ).

In August, BF Biosciences successfully launched human insulin under the brand name "Ferulin".

BF Biosciences was established exclusively for the manufacture of biologicals and it is the first and only company in Pakistan currently to have a biotech manufacturing facility.

Copyright Mettis Link News

Related News

TRG case files stolen en route to Islamabad

PSX Closing Bell: On the Rise

MTL expected to climb to Rs650/share by Dec 2025

Name	Price/Vol	%Chg/NChg
KSE100	136,379.97 273.10M	0.32% 440.10
ALLSHR	84,648.35 701.94M	0.06% 47.97
KSE30	41,546.23 70.12M	0.42% 172.55
KMI30	191,719.76 71.30M	0.34% 649.79
KMIALLSHR	55,827.74 371.98M	0.16% 89.67
BKTi	37,827.61 18.93M	-1.72% -662.14
OGTi	27,670.67 7.41M	-0.42% -117.47

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	118,400.00	119,915.00 118,035.00	-1230.00 -1.03%
BRENT CRUDE	68.97	69.01 68.74	0.45 0.66%
RICHARDS BAY COAL MONTHLY	96.50	0.00 0.00	1.80 1.90%
ROTTERDAM COAL MONTHLY	104.50	0.00 0.00	-1.05 -0.99%
USD RBD PALM OLEIN	998.50	998.50 998.50	0.00 0.00%
CRUDE OIL - WTI	66.92	66.99 66.58	0.54 0.81%
SUGAR #11 WORLD	16.55	16.67 16.40	-0.01 -0.06%